Investing.com - Eli Lilly (NYSE:LLY) reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Eli Lilly announced earnings per share of $1.54 on revenue of $5.74B. Analysts polled by Investing.com anticipated EPS of $1.71 on revenue of $5.87B.
Eli Lilly shares are up 7% from the beginning of the year and are trading at $141.70 , down-from-52-week-high.They are outperforming the S&P 500 which is up 5.27% from the start of the year.
Eli Lilly follows other major Healthcare sector earnings this month
Eli Lilly's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Abbott Labs had beat expectations on Wednesday, October 21, 2020 with third quarter EPS of $0.98 on revenue of $8.85B, compared to forecast for EPS of $0.91 on revenue of $8.54B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar